Related Experiment Video
Updated: Jul 29, 2026

10:43
Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
Published on: October 31, 2007
Insulinoma in chronic renal failure: a case report
Ananda Basu1, Michael T Sheehan, Geoffrey B Thompson
1Marshfield Clinic, Wausau, Wisconsin 54401, USA. basu.ananda@mayo.edu
The Journal of Clinical Endocrinology and Metabolism
|November 5, 2002
Summary
Diagnosing insulinoma in patients with renal impairment is challenging due to altered fasting test results. Endoscopic ultrasonography aided in identifying insulinoma in a renal transplant patient with a history of hypoglycemia.
Area of Science:
- Endocrinology
- Nephrology
- Gastroenterology
Background:
- Insulinoma diagnosis typically relies on a 72-hour fast, but renal function can complicate interpretation.
- Renal failure can cause spontaneous hypoglycemia unrelated to insulinoma.
- This case highlights diagnostic challenges in patients with impaired renal function.
Observation:
- A patient with a history of renal impairment and transplant experienced hypoglycemic symptoms for 20 years.
- Standard 72-hour fasting tests suggested endogenous hyperinsulinemia but were complicated by renal impairment.
- Endoscopic ultrasonography was crucial for locating the insulinoma.
Findings:
- Successful surgical resection of the insulinoma was performed.
- This case represents one of the few documented instances of insulinoma in a patient with concurrent renal failure.
- Endoscopic ultrasonography proved effective for tumor localization when fasting tests were equivocal.
Implications:
- The diagnostic criteria for insulinoma may need adjustment in patients with renal impairment.
- Endoscopic ultrasonography is a valuable tool for diagnosing insulinoma in complex renal cases.
- Further research is needed to understand hypoglycemia in renal failure and its distinction from insulinoma.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Dialysis
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

